Highlights
NASDAQ: ADVM       Adverum Biotechnlgs
Last Price Today's Change   Day's Range   Trading Volume
8.89   +0.16 (1.83%)  8.55 - 8.99  223,794

Overview

 
Avg Volume (4 weeks):1,130,430
4 Weeks Range:6.23 - 9.37
4 Weeks Price Volatility (%):
84.71%
52 Weeks Range:2.81 - 16.383
52 Weeks Price Volatility (%):
44.79%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. The company is committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye, who currently have limited or burdensome treatment options. Its services are focused on advancing three lead gene therapy programs to address unmet needs in wet age-related macular degeneration and in rare diseases alpha-1 antitrypsin deficiency and hereditary angioedema. Its leading programs include ADVM-022, ADVM-043 and ADVM-053.

  Be the first to like this.
 


 

2954  2614  494  2908 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.827+0.282 
 AMD 37.52+0.81 
 ET 11.16-0.50 
 GE 11.29-0.13 
 AABA 19.630.00 
 DIS 148.72+10.14 
 BAC 32.79-0.30 
 F 8.81-0.23 
 UBER 26.71+0.01 
Partners & Brokers